Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

HPV genes and estradiol increase a cancer-related signaling pathway, which may be targeted for cervical cancer treatment.

Women with PCOS and polycystic ovaries have higher male hormone levels and more insulin resistance, especially if they are overweight.

Changes in keratin affect skin health and can lead to skin disorders like blistering diseases and psoriasis.

Certain drugs that block specific enzymes can help treat prostate diseases.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Antiandrogens are effective for conditions like prostate cancer and skin issues, but more research is needed to confirm their benefits and minimize side effects.

The method accurately measures sex hormones in human plasma but can have small errors.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

Sebaceous glands age due to genetic and environmental factors, affecting sebum production and composition.

Localized heat or specific injections can prevent chemotherapy-induced hair loss without affecting cancer treatment.

PCOS is a complex condition in women that can lead to health issues, and lifestyle changes are the best management approach.

Cyproterone acetate is used to treat conditions like prostate cancer, early puberty, excessive sexual drive, and female androgenization by affecting androgen functions and suppressing certain hormones.

The document explains different hair and scalp conditions, including common hair loss after pregnancy or illness, drug-induced hair loss, hereditary excessive hair growth, patterned baldness, autoimmune hair loss, and permanent loss due to skin disease, with generally limited treatment options.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

A woman's mature cystic teratoma caused her virilization by producing testosterone.

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.

Hormone imbalances from the pituitary, thyroid, and adrenal glands can cause infertility, but treating these disorders can improve fertility.

Active oxygen species might be involved in skin tumor growth, but their exact role is unclear.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Sertoliform endometrioid carcinoma of the ovary, though rare, has a good prognosis when treated early.

Terbinafine can cause hair loss.

Cyclosporin doesn't stop hair loss.

PCOS management includes lifestyle changes and medications to improve fertility.

Dermatologists give better information on pathology forms, hypersensitivity vasculitis is a common skin issue, misdiagnoses can occur, and various skin conditions are linked to loss of elastin or genetic factors.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

New findings explain how genetic changes, body clocks, and certain molecules affect tissue response to stress hormones.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.